Related Experiment Videos
[Specific immunotherapy of respiratory allergies]
J Bousquet1, P Demoly, P Chanez
1Service des Maladies Respiratoires, Hôpital Arnaud de Villeneuve, Montpellier.
Bulletin De L'Academie Nationale De Medecine
|April 29, 1998
Summary
Specific immunotherapy, used since 1911, effectively treats allergic rhinoconjunctivitis and asthma. Advances in extracts, understanding mechanisms, and new routes solidify its role in managing respiratory allergies.
Area of Science:
- Immunology
- Allergology
- Respiratory Medicine
Context:
- Specific immunotherapy (SI) has been utilized for respiratory allergic diseases since 1911.
- Controversies persist regarding the precise indications for SI.
- Recent advancements have addressed these uncertainties.
Purpose:
- To review the established efficacy and evolving role of specific immunotherapy in respiratory allergic diseases.
- To highlight factors legitimizing its therapeutic use.
Summary:
- Efficacy of SI is confirmed by double-blind, placebo-controlled studies in allergic rhinoconjunctivitis and asthma.
- Improvements in allergenic extract standardization enhance treatment reliability.
- Enhanced understanding of immunotherapy mechanisms and exploration of alternative administration routes are key developments.
Impact:
- Standardized extracts and improved mechanistic understanding support SI's established role.
- Guidelines and new administration routes further legitimize SI in clinical practice.
- SI remains a vital therapeutic option for allergic respiratory conditions.